nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—MUSK—ECM proteoglycans—COL9A3—degenerative disc disease	0.0874	0.0874	CbGpPWpGaD
Sorafenib—MUSK—ECM proteoglycans—COL9A2—degenerative disc disease	0.0682	0.0682	CbGpPWpGaD
Sorafenib—CSF1R—Differentiation Pathway—GDF5—degenerative disc disease	0.0451	0.0451	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—GDF5—degenerative disc disease	0.0312	0.0312	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.0249	0.0249	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—COL9A3—degenerative disc disease	0.0249	0.0249	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.0249	0.0249	CbGpPWpGaD
Sorafenib—KIT—Differentiation Pathway—GDF5—degenerative disc disease	0.0225	0.0225	CbGpPWpGaD
Sorafenib—EPHX2—Metapathway biotransformation—CHST3—degenerative disc disease	0.0223	0.0223	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.0212	0.0212	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—COL9A2—degenerative disc disease	0.0194	0.0194	CbGpPWpGaD
Sorafenib—KDR—Integrin cell surface interactions—COL9A3—degenerative disc disease	0.018	0.018	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—SOX9—degenerative disc disease	0.0162	0.0162	CbGpPWpGaD
Sorafenib—RET—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—degenerative disc disease	0.0157	0.0157	CbGpPWpGaD
Sorafenib—MAPK11—Parkinsons Disease Pathway—PARK2—degenerative disc disease	0.0146	0.0146	CbGpPWpGaD
Sorafenib—KDR—Integrin cell surface interactions—COL9A2—degenerative disc disease	0.0141	0.0141	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—ADAMTS5—degenerative disc disease	0.0136	0.0136	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—MMP13—degenerative disc disease	0.0134	0.0134	CbGpPWpGaD
Sorafenib—FGFR1—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0129	0.0129	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—BMP2—degenerative disc disease	0.0129	0.0129	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—ADAMTS4—degenerative disc disease	0.0116	0.0116	CbGpPWpGaD
Sorafenib—FGFR1—Neural Crest Differentiation—SOX9—degenerative disc disease	0.0113	0.0113	CbGpPWpGaD
Sorafenib—MAP3K7—BMP receptor signaling—BMP2—degenerative disc disease	0.0104	0.0104	CbGpPWpGaD
Sorafenib—RAF1—NCAM signaling for neurite out-growth—COL9A3—degenerative disc disease	0.0104	0.0104	CbGpPWpGaD
Sorafenib—FGFR1—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.0101	0.0101	CbGpPWpGaD
Sorafenib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP13—degenerative disc disease	0.0092	0.0092	CbGpPWpGaD
Sorafenib—MUSK—Extracellular matrix organization—MMP3—degenerative disc disease	0.00897	0.00897	CbGpPWpGaD
Sorafenib—EPHB6—Axon guidance—COL9A3—degenerative disc disease	0.00826	0.00826	CbGpPWpGaD
Sorafenib—RAF1—NCAM signaling for neurite out-growth—COL9A2—degenerative disc disease	0.00809	0.00809	CbGpPWpGaD
Sorafenib—EPHA6—Axon guidance—COL9A3—degenerative disc disease	0.00776	0.00776	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—GDF5—degenerative disc disease	0.00743	0.00743	CbGpPWpGaD
Sorafenib—FGFR1—Endochondral Ossification—MMP13—degenerative disc disease	0.00731	0.00731	CbGpPWpGaD
Sorafenib—UGT1A1—Metapathway biotransformation—CHST3—degenerative disc disease	0.0066	0.0066	CbGpPWpGaD
Sorafenib—UGT1A9—Metapathway biotransformation—CHST3—degenerative disc disease	0.0066	0.0066	CbGpPWpGaD
Sorafenib—EPHB6—Axon guidance—COL9A2—degenerative disc disease	0.00645	0.00645	CbGpPWpGaD
Sorafenib—KIT—Signaling by PDGF—COL9A3—degenerative disc disease	0.0062	0.0062	CbGpPWpGaD
Sorafenib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—degenerative disc disease	0.00616	0.00616	CbGpPWpGaD
Sorafenib—EPHA6—Axon guidance—COL9A2—degenerative disc disease	0.00606	0.00606	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—COL9A3—degenerative disc disease	0.00594	0.00594	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—ADAMTS5—degenerative disc disease	0.00594	0.00594	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—ADAMTS3—degenerative disc disease	0.00594	0.00594	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—COL9A3—degenerative disc disease	0.00589	0.00589	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by PDGF—COL9A3—degenerative disc disease	0.00589	0.00589	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by PDGF—COL9A3—degenerative disc disease	0.00587	0.00587	CbGpPWpGaD
Sorafenib—RAF1—Oncostatin M Signaling Pathway—MMP13—degenerative disc disease	0.00578	0.00578	CbGpPWpGaD
Sorafenib—RAF1—AGE/RAGE pathway—MMP13—degenerative disc disease	0.00571	0.00571	CbGpPWpGaD
Sorafenib—CYP3A7—Metapathway biotransformation—CHST3—degenerative disc disease	0.00555	0.00555	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—COL9A3—degenerative disc disease	0.00554	0.00554	CbGpPWpGaD
Sorafenib—BRAF—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.0055	0.0055	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by PDGF—COL9A3—degenerative disc disease	0.00529	0.00529	CbGpPWpGaD
Sorafenib—MAP2K5—BDNF signaling pathway—BMP2—degenerative disc disease	0.00514	0.00514	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—ADAMTS4—degenerative disc disease	0.00505	0.00505	CbGpPWpGaD
Sorafenib—MAPK11—Metabolism of mRNA—RPL34—degenerative disc disease	0.00504	0.00504	CbGpPWpGaD
Sorafenib—KDR—Axon guidance—COL9A3—degenerative disc disease	0.00504	0.00504	CbGpPWpGaD
Sorafenib—KIT—Signaling by PDGF—COL9A2—degenerative disc disease	0.00484	0.00484	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—COL9A3—degenerative disc disease	0.00472	0.00472	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—COL9A2—degenerative disc disease	0.00464	0.00464	CbGpPWpGaD
Sorafenib—EPHB6—Developmental Biology—COL9A2—degenerative disc disease	0.0046	0.0046	CbGpPWpGaD
Sorafenib—FGFR1—Signaling by PDGF—COL9A2—degenerative disc disease	0.0046	0.0046	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling by PDGF—COL9A2—degenerative disc disease	0.00458	0.00458	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—COL9A2—degenerative disc disease	0.00432	0.00432	CbGpPWpGaD
Sorafenib—MAPK11—Metabolism of RNA—RPL34—degenerative disc disease	0.00432	0.00432	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling by PDGF—COL9A2—degenerative disc disease	0.00413	0.00413	CbGpPWpGaD
Sorafenib—CYP2B6—Metapathway biotransformation—CHST3—degenerative disc disease	0.0041	0.0041	CbGpPWpGaD
Sorafenib—CYP3A5—Metapathway biotransformation—CHST3—degenerative disc disease	0.00401	0.00401	CbGpPWpGaD
Sorafenib—KDR—Axon guidance—COL9A2—degenerative disc disease	0.00394	0.00394	CbGpPWpGaD
Sorafenib—RAF1—Oncostatin M Signaling Pathway—MMP3—degenerative disc disease	0.00387	0.00387	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—CHST3—degenerative disc disease	0.00387	0.00387	CbGpPWpGaD
Sorafenib—RAF1—Senescence and Autophagy in Cancer—BMP2—degenerative disc disease	0.0038	0.0038	CbGpPWpGaD
Sorafenib—MKNK1—Disease—CHST3—degenerative disc disease	0.00376	0.00376	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—COL9A3—degenerative disc disease	0.00371	0.00371	CbGpPWpGaD
Sorafenib—RAF1—Signaling by PDGF—COL9A2—degenerative disc disease	0.00368	0.00368	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—COL9A3—degenerative disc disease	0.0036	0.0036	CbGpPWpGaD
Sorafenib—CYP2C8—Metapathway biotransformation—CHST3—degenerative disc disease	0.00348	0.00348	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—MMP13—degenerative disc disease	0.0032	0.0032	CbGpPWpGaD
Sorafenib—CYP2C19—Metapathway biotransformation—CHST3—degenerative disc disease	0.0031	0.0031	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—COL9A3—degenerative disc disease	0.00309	0.00309	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—BMP2—degenerative disc disease	0.00309	0.00309	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—COL9A3—degenerative disc disease	0.00297	0.00297	CbGpPWpGaD
Sorafenib—RAF1—BDNF signaling pathway—BMP2—degenerative disc disease	0.00295	0.00295	CbGpPWpGaD
Sorafenib—FGFR1—Axon guidance—COL9A2—degenerative disc disease	0.0029	0.0029	CbGpPWpGaD
Sorafenib—CYP2D6—Metapathway biotransformation—CHST3—degenerative disc disease	0.00285	0.00285	CbGpPWpGaD
Sorafenib—CYP2C9—Metapathway biotransformation—CHST3—degenerative disc disease	0.00283	0.00283	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—COL9A2—degenerative disc disease	0.00281	0.00281	CbGpPWpGaD
Sorafenib—CDK7—Disease—CHST3—degenerative disc disease	0.00265	0.00265	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—COL9A3—degenerative disc disease	0.00265	0.00265	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—COL9A3—degenerative disc disease	0.00245	0.00245	CbGpPWpGaD
Sorafenib—MKNK1—Disease—RPL34—degenerative disc disease	0.00243	0.00243	CbGpPWpGaD
Sorafenib—CYP1A2—Metapathway biotransformation—CHST3—degenerative disc disease	0.00242	0.00242	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—COL9A2—degenerative disc disease	0.00242	0.00242	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—COL9A3—degenerative disc disease	0.00241	0.00241	CbGpPWpGaD
Sorafenib—RAF1—Axon guidance—COL9A2—degenerative disc disease	0.00232	0.00232	CbGpPWpGaD
Sorafenib—KDR—Extracellular matrix organization—MMP3—degenerative disc disease	0.00214	0.00214	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—COL9A3—degenerative disc disease	0.00212	0.00212	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—COL9A2—degenerative disc disease	0.00207	0.00207	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—COL9A3—degenerative disc disease	0.002	0.002	CbGpPWpGaD
Sorafenib—BRAF—Disease—CHST3—degenerative disc disease	0.00192	0.00192	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—COL9A2—degenerative disc disease	0.00191	0.00191	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—COL9A2—degenerative disc disease	0.00188	0.00188	CbGpPWpGaD
Sorafenib—CYP3A4—Metapathway biotransformation—CHST3—degenerative disc disease	0.00187	0.00187	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—RPL34—degenerative disc disease	0.00184	0.00184	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—COL9A3—degenerative disc disease	0.0018	0.0018	CbGpPWpGaD
Sorafenib—KIT—Disease—CHST3—degenerative disc disease	0.00175	0.00175	CbGpPWpGaD
Sorafenib—CDK7—Disease—RPL34—degenerative disc disease	0.00171	0.00171	CbGpPWpGaD
Sorafenib—FGFR1—Disease—CHST3—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—COL9A2—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—CHST3—degenerative disc disease	0.00166	0.00166	CbGpPWpGaD
Sorafenib—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.00159	0.00159	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—COL9A2—degenerative disc disease	0.00156	0.00156	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—CHST3—degenerative disc disease	0.00149	0.00149	CbGpPWpGaD
Sorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.00149	0.00149	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—PARK2—degenerative disc disease	0.00143	0.00143	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—PARK2—degenerative disc disease	0.00143	0.00143	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—COL9A2—degenerative disc disease	0.0014	0.0014	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—PARK2—degenerative disc disease	0.00136	0.00136	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—PARK2—degenerative disc disease	0.00136	0.00136	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—RPL34—degenerative disc disease	0.00135	0.00135	CbGpPWpGaD
Sorafenib—RAF1—Disease—CHST3—degenerative disc disease	0.00133	0.00133	CbGpPWpGaD
Sorafenib—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—degenerative disc disease	0.00128	0.00128	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—BMP2—degenerative disc disease	0.00127	0.00127	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—BMP2—degenerative disc disease	0.00125	0.00125	CbGpPWpGaD
Sorafenib—BRAF—Disease—RPL34—degenerative disc disease	0.00124	0.00124	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—COL9A3—degenerative disc disease	0.00123	0.00123	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—PARK2—degenerative disc disease	0.00122	0.00122	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—COL9A3—degenerative disc disease	0.0012	0.0012	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CHST3—degenerative disc disease	0.00114	0.00114	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CHST3—degenerative disc disease	0.00114	0.00114	CbGpPWpGaD
Sorafenib—KIT—Disease—RPL34—degenerative disc disease	0.00113	0.00113	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—PARK2—degenerative disc disease	0.00109	0.00109	CbGpPWpGaD
Sorafenib—FGFR1—Disease—RPL34—degenerative disc disease	0.00107	0.00107	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—RPL34—degenerative disc disease	0.00107	0.00107	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—BMP2—degenerative disc disease	0.00104	0.00104	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—COL9A3—degenerative disc disease	0.00103	0.00103	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—COL9A3—degenerative disc disease	0.00102	0.00102	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CHST3—degenerative disc disease	0.000971	0.000971	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—PARK2—degenerative disc disease	0.000965	0.000965	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CHST3—degenerative disc disease	0.000962	0.000962	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—RPL34—degenerative disc disease	0.000961	0.000961	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—COL9A2—degenerative disc disease	0.000959	0.000959	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—COL9A2—degenerative disc disease	0.000934	0.000934	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—BMP2—degenerative disc disease	0.000934	0.000934	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—COL9A3—degenerative disc disease	0.000928	0.000928	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—COL9A3—degenerative disc disease	0.000928	0.000928	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—MMP3—degenerative disc disease	0.000882	0.000882	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—COL9A3—degenerative disc disease	0.000881	0.000881	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—COL9A3—degenerative disc disease	0.000879	0.000879	CbGpPWpGaD
Sorafenib—KIT—Immune System—PARK2—degenerative disc disease	0.00087	0.00087	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—PARK2—degenerative disc disease	0.00087	0.00087	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—MMP3—degenerative disc disease	0.000868	0.000868	CbGpPWpGaD
Sorafenib—RAF1—Disease—RPL34—degenerative disc disease	0.000857	0.000857	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—PARK2—degenerative disc disease	0.000825	0.000825	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—PARK2—degenerative disc disease	0.000823	0.000823	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—COL9A2—degenerative disc disease	0.000804	0.000804	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—COL9A2—degenerative disc disease	0.000796	0.000796	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—COL9A3—degenerative disc disease	0.000792	0.000792	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—COL9A3—degenerative disc disease	0.000755	0.000755	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—PARK2—degenerative disc disease	0.000742	0.000742	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—COL9A2—degenerative disc disease	0.000725	0.000725	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—COL9A2—degenerative disc disease	0.000725	0.000725	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—MMP3—degenerative disc disease	0.000719	0.000719	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CHST3—degenerative disc disease	0.000712	0.000712	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—COL9A3—degenerative disc disease	0.000705	0.000705	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CHST3—degenerative disc disease	0.000696	0.000696	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—COL9A2—degenerative disc disease	0.000688	0.000688	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—COL9A2—degenerative disc disease	0.000686	0.000686	CbGpPWpGaD
Sorafenib—RAF1—Immune System—PARK2—degenerative disc disease	0.000661	0.000661	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—MMP3—degenerative disc disease	0.000648	0.000648	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—BMP2—degenerative disc disease	0.000638	0.000638	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—BMP2—degenerative disc disease	0.000622	0.000622	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—COL9A2—degenerative disc disease	0.000618	0.000618	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—COL9A3—degenerative disc disease	0.000609	0.000609	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CHST3—degenerative disc disease	0.000603	0.000603	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—COL9A2—degenerative disc disease	0.000589	0.000589	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—COL9A2—degenerative disc disease	0.000551	0.000551	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CHST3—degenerative disc disease	0.000538	0.000538	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—BMP2—degenerative disc disease	0.000535	0.000535	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—BMP2—degenerative disc disease	0.00053	0.00053	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CHST3—degenerative disc disease	0.000525	0.000525	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CHST3—degenerative disc disease	0.000495	0.000495	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CHST3—degenerative disc disease	0.00049	0.00049	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—BMP2—degenerative disc disease	0.000482	0.000482	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—BMP2—degenerative disc disease	0.000482	0.000482	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—COL9A2—degenerative disc disease	0.000475	0.000475	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—MMP3—degenerative disc disease	0.00046	0.00046	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—BMP2—degenerative disc disease	0.000458	0.000458	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—BMP2—degenerative disc disease	0.000456	0.000456	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—MMP3—degenerative disc disease	0.000442	0.000442	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—MMP3—degenerative disc disease	0.000431	0.000431	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—MMP3—degenerative disc disease	0.00043	0.00043	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CHST3—degenerative disc disease	0.000419	0.000419	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—BMP2—degenerative disc disease	0.000411	0.000411	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—BMP2—degenerative disc disease	0.000392	0.000392	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—MMP3—degenerative disc disease	0.000371	0.000371	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—MMP3—degenerative disc disease	0.000371	0.000371	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—MMP3—degenerative disc disease	0.000367	0.000367	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—BMP2—degenerative disc disease	0.000366	0.000366	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—MMP3—degenerative disc disease	0.000334	0.000334	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—MMP3—degenerative disc disease	0.000334	0.000334	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CHST3—degenerative disc disease	0.000323	0.000323	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—MMP3—degenerative disc disease	0.000317	0.000317	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—MMP3—degenerative disc disease	0.000316	0.000316	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—BMP2—degenerative disc disease	0.000316	0.000316	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—MMP3—degenerative disc disease	0.000285	0.000285	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—MMP3—degenerative disc disease	0.000272	0.000272	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—MMP3—degenerative disc disease	0.000254	0.000254	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—MMP3—degenerative disc disease	0.000219	0.000219	CbGpPWpGaD
